[Form 4] SECURITY NATIONAL FINANCIAL CORP Insider Trading Activity

Rhea-AI Filing Summary

Security National Financial Corp (SNFCA) director H. Craig Moody reported share and option activity on a Form 4. The filing shows the acquisition of 627 Class A shares via a restricted stock unit vesting event at a price of $13.08, increasing his direct non-derivative holdings to 43,702 shares. The report also details multiple outstanding director stock options and previously granted restricted stock units, which together result in beneficial ownership of 61,276 Class A shares when including exercisable options and RSUs.

The filing documents option grants from 2016–2024 with exercise prices adjusted for stock dividends and vesting/exercise windows ranging through 2033. The newly vested units will be fully vested on 12/31/2025 per the disclosed schedule.

Positive

• Director acquired 627 RSUs that increase direct alignment with shareholders at $13.08
• Comprehensive disclosure of directors' options and RSUs with adjusted exercise prices shows governance transparency
• Vesting schedule provided with full vesting on 12/31/2025, making timing of ownership changes clear

Negative

• Meaningful potential dilution exists from outstanding director options and RSUs totaling 61,276 shares if exercised or vested
• Concentration of option expirations across 2026–2033 could lead to clustered share supply increases in those windows

Insights

Equity Compensation Specialist

TL;DR: Director received 627 RSUs vesting at $13.08, increasing total beneficial holdings to 61,276 shares.

The transaction listed is a restricted stock unit vesting/acquisition of 627 Class A shares at $13.08, reported under a Form 4 for a company director. The filing also itemizes serial director stock options granted from 2016 through 2023, with adjusted exercise prices reflecting repeated stock dividends.

Key dependencies include the remaining vesting windows and option expiration dates through 2033, which determine when these derivative interests can convert to shares and potentially dilute existing holders. Watch vesting completion on 12/31/2025 and option expiration clustering in the 2026–2033 range for near-term share supply changes.

Corporate Governance Analyst

TL;DR: Report confirms director-level equity compensation activity and beneficial ownership disclosure.

The Form 4 confirms the reporting person is a director and provides transparent disclosure of direct holdings (43,702 shares) plus derivative instruments and RSUs totaling 61,276 shares beneficially owned when combined. Multiple adjustments for stock dividends are documented, showing plan anti-dilution mechanics applied over several years.

This disclosure fulfills Section 16 reporting obligations and gives investors clarity on director exposure. Monitor additional periodic filings for further vesting events or option exercises that change director ownership concentration.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MOODY H. CRAIG

(Last) (First) (Middle)

11892 SOUTH BROOKGLEN DRIVE

(Street)

SANDY UT 84092

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
SECURITY NATIONAL FINANCIAL CORP [ snfca ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
10/01/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	10/01/2025	10/01/2025	M		627	A	$13.08	43,702(1)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Director Stock Option (right to buy)	$4.32(2)	12/02/2016		A		7,952		03/02/2017	12/02/2026	Class A Common Stock	7,952	$4.32	7,952	D
Director Stock Option (right to buy)	$4.52(3)	12/07/2016		A		1,590		03/07/2017	12/07/2026	Class A Common Stock	1,590	$4.52	9,542	D
Director Stock Option (right to buy)	$3.27(4)	12/01/2017		A		1,514		03/01/2018	12/01/2027	Class A Common Stock	1,514	$3.27	11,056	D
Director Stock Option (right to buy)	$3.76(5)	11/30/2018		A		8,657		02/28/2019	11/30/2028	Class A Common Stock	8,657	$3.76	19,713	D
Director Stock Option (right to buy)	$3.91(6)	12/06/2019		A		8,242		03/06/2020	12/06/2029	Class A Common Stock	8,242	$3.91	27,955	D
Director Stock Option (right to buy)	$2.84(7)	03/27/2020		A		7,850		06/27/2020	03/27/2030	Class A Common Stock	7,850	$2.84	35,805	D
Director Stock Option (right to buy)	$7.02(8)	12/03/2021		A		7,293		03/03/2022	12/03/2031	Class A Common Stock	7,293	$7.02	43,098	D
Director Stock Option (right to buy)	$5.56(9)	12/02/2022		A		8,104		03/02/2023	12/02/2032	Class A Common Stock	8,104	$5.56	51,202	D
Director Stock Option (right to buy)	$7.21(10)	12/01/2023		A		8,820		03/01/2024	12/01/2033	Class A Common Stock	8,820	$7.21	60,022	D
Restricted Stock Unit	$13.08(11)	12/06/2024		A		1,254		04/01/2025	12/31/2025	Class A Common Stock	1,254	$13.08	61,276	D
Restricted Stock Unit	$13.08(11)	10/01/2025	10/01/2025	A			627	04/01/2025	12/31/2025	Class A Common Stock	627	$13.08	60,649	D

Explanation of Responses:

1. Adjusted to reflect a 5% stock dividend issued on July 18, 2025.

2. This option was granted on December 2, 2016 as an option for 5,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.03 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 8, 2022, July 14, 2023, July 12, 2024 and July 18, 2025.

3. This option was granted on December 7, 2016 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $7.36 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 3, 2017, February 2, 2018, February 1, 2019, and February 7, 2020; a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 8, 2022, July 14, 2023, July 12, 2024 and July 18, 2025.

4. This option was granted on December 1, 2017 as an option for 1,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.05 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 2, 2018, February 1, 2019, and February 7, 2020; a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 8, 2022, July 14, 2023, July 12, 2024 and July 18, 2025.

5. This option was granted on November 30, 2018 as an option for 6,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.52 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect 5% stock dividends paid on February 1, 2019 and February 7, 2020; a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 8, 2022, July 14, 2023, July 12, 2024 and July 18, 2025.

6. This option was granted on December 6, 2019 as an option for 6,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $5.46 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 7, 2020; a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 8, 2022, July 14, 2023, July 12, 2024 and July 18, 2025.

7. This option was granted on March 27, 2020 as an option for 6,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $3.76 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on February 7, 2020, a 2.5% stock dividend paid on July 17, 2020; a 5% stock dividend paid on July 16, 2021, July 8, 2022, July 14, 2023, July 12, 2024 and July 18, 2025.

8. This option was granted on December 3, 2021 as an option for 6,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $8.62 per share, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on July 8, 2022, July 14, 2023, July 12, 2024 and July 18, 2025.

9. This option was granted on December 2, 2022 as an option for 7,000 shares of Class A Common Stock under the 2014 Director Stock Option Plan at an exercise price of $6.48, but adjusted pursuant to the anti-dilution provisions of the 2014 Director Stock Option Plan to reflect a 5% stock dividend paid on July 14, 2023, July 12, 2024 and July 18, 2025.

10. This option was granted on December 1, 2023 as an option for 8,000 shares of Class A Common Stock under the 2022 Equity Incentive Plan at an exercise price of $7.99 per share, but adjusted pursuant to the 2022 Equity Incentive Plan to reflect a 5% stock dividend paid on July 12, 2024 and July 18, 2025.

11. These restricted stock units were granted on December 6, 2024 for 2,509 shares of Class A Common Stock under the 2022 Equity Incentive Plan at a price of $13.08 per share. The units granted vest quarterly, and will be fully vested on December 31, 2025.

	/s/ H. Craig Moody	10/06/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Security National Financial (SNFCA) director H. Craig Moody acquire?

The director acquired 627 Class A shares via restricted stock units vesting at $13.08 per share.

How many shares does H. Craig Moody beneficially own after this Form 4?

The filing shows direct non-derivative holdings of 43,702 shares and total beneficial ownership including derivatives of 61,276 Class A shares.

When do the newly reported restricted stock units fully vest?

The restricted stock units vest quarterly and will be fully vested on 12/31/2025.

What is the range of exercise prices for the director stock options disclosed?

Exercise prices for disclosed director stock options range from $2.84 (post-adjustment) up to $7.21, with earlier listed original prices noted in the explanations.

Do the option and RSU amounts reflect adjustments?

Yes. The filing states multiple adjustments to option quantities and exercise prices to reflect repeated stock dividends paid between 2017 and 2025.